This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Louie, B.
Right arrow Articles by Pandori, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Louie, B.
Right arrow Articles by Pandori, M. W.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2008, p. 1494-1497, Vol. 46, No. 4
0095-1137/08/$08.00+0     doi:10.1128/JCM.01945-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Assessment of Rapid Tests for Detection of Human Immunodeficiency Virus-Specific Antibodies in Recently Infected Individuals{triangledown}

Brian Louie,1* Ernest Wong,1 Jeffrey D. Klausner,1,2 Sally Liska,1 Frederick Hecht,2 Terri Dowling,1 Martha Obeso,1 Susan S. Phillips,1 and Mark W. Pandori1

San Francisco Department of Public Health, San Francisco, California,1 University of California, San Francisco, San Francisco, California2

Received 2 October 2007/ Returned for modification 11 January 2008/ Accepted 22 January 2008

We have evaluated four current Food and Drug Administration-cleared rapid tests for human immunodeficiency virus (HIV)-specific antibodies with a panel of specimens from recently infected individuals. Recent infection was detected by RNA-based screening coupled with enzyme immunoassay-based testing. We found that the sensitivities of the various rapid tests vary greatly with regard to their ability to detect HIV-specific antibodies in recently infected individuals.

* Corresponding author. Mailing address: San Francisco Department of Public Health, 101 Grove St., Room 412, San Francisco, CA 94102. Phone: (415) 554-2800. Fax: (415) 431-0651. E-mail: brian.louie{at}sfdph.org

{triangledown} Published ahead of print on 30 January 2008.

Journal of Clinical Microbiology, April 2008, p. 1494-1497, Vol. 46, No. 4
0095-1137/08/$08.00+0     doi:10.1128/JCM.01945-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Mayhood, M. K., Afwamba, I. A., Odhiambo, C. O., Ndanu, E., Thielman, N. M., Morrissey, A. B., Shao, J. F., Wells Pence, B., Crump, J. A. (2008). Validation, Performance under Field Conditions, and Cost-Effectiveness of Capillus HIV-1/HIV-2 and Determine HIV-1/2 Rapid Human Immunodeficiency Virus Antibody Assays Using Sequential and Parallel Testing Algorithms in Tanzania. J. Clin. Microbiol. 46: 3946-3951 [Abstract] [Full Text]  
  • Ren, A., Louie, B., Rauch, L., Castro, L., Liska, S., Klausner, J. D., Pandori, M. W. (2008). Screening and confirmation of human immunodeficiency virus type 1 infection solely by detection of RNA. J Med Microbiol 57: 1228-1233 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»